ReviewStem cell research & therapy2021
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Ehsan Razeghian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
74 papers cite itlatest 60 shown
this papercites it